• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

EVOTF:US

3.8000 USD 1.1500 23.23%

As of 10:54:24 ET on 10/01/2014.

Snapshot for Evotec AG (EVOTF)

Open: 3.8000 Day's Range: 3.8000 - 3.8000 Volume: 5,200
Previous Close: 4.9500 52wk Range: 3.8000 - 6.2900 1-Yr Rtn: -

Stock Chart for EVOTF

No chart data available.
  • EVOTF:US 3.8000
  • 1D
  • 1M
  • 1Y
4.9500
Interactive EVOTF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EVOTF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.0230
Est. PEG Ratio -
Market Cap (M USD) 500.40
Shares Outstanding (M) 131.68
30 Day Average Volume 11
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EVOTF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for EVOTF

Evotec AG offers drug research, development, and manufacturing services. The Company offers assay development and screening and compound optimization services to pharmaceutical companies. Evotec also develops drugs on its own for out-licensing.

Werner LanthalerChief Executive OfficerColin BondCFO/Member-Mgmt Board
Mario PolywkaCOO/Member-Mgmt BdCord E DohrmannChief Scientific Officer
More Company Profile & Key Executives for EVOTF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil